Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 08 2022
Historique:
received: 29 03 2022
accepted: 05 05 2022
pubmed: 12 5 2022
medline: 9 6 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

Recognizing bipolar disorder as a multi-system metabolic condition driven, in part, by binge eating behavior and atypical depressive symptoms, this study aimed to quantify diet quality and evaluate clinical correlates in a bipolar disorder cohort. Participants from the Mayo Clinic Bipolar Disorder Biobank (n = 734) completed the Rapid Eating Assessment for Participants - Shortened version (REAP-S) to determine diet quality. The average REAP-S score for a U.S. omnivorous diet is 32 (range 13 to 39) with higher scores indicating healthier diet. Demographic variables were collected in a standardized clinical questionnaire. Depressive symptoms were assessed by the Bipolar Inventory of Symptoms Scale. Cardiometabolic variables were retrieved from the electronic health record. Associations between continuous variables and REAP-S scores (total, 'healthy foods' and 'avoidance of unhealthy foods') were assessed using linear regression. Overall, our sample had a mean REAP-S score of 27.6 (4.9), suggestive of a lower diet quality than the average general population in the US. There was a significant inverse relationship between mean REAP-S lower scores with increased BMI, waist circumference, disordered eating and depression. All these associations were significantly stronger in female participants. EHR cross-sectional data. Our data suggest unhealthy diet quality in bipolar disorder is associated with depression, obesity and cardiometabolic abnormalities. Additional work is encouraged to prospectively track mood and diet quality to further understand the bidirectional relationship and clarify if dietary interventions can positively impact mood. Further delineating potential sex differences in diet quality and depression may provide greater appreciation of modifiable risk factors for future cardiometabolic burden.

Identifiants

pubmed: 35545158
pii: S0165-0327(22)00539-0
doi: 10.1016/j.jad.2022.05.037
pmc: PMC9721194
mid: NIHMS1851063
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

150-155

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH120503
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002379
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Références

J Affect Disord. 2008 Feb;106(1-2):91-7
pubmed: 17628693
Bipolar Disord. 2019 Feb;21(1):40-49
pubmed: 30051546
Diabetes Educ. 2004 Sep-Oct;30(5):774, 776, 778 passim
pubmed: 15510530
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Psychol Med. 2021 Mar 26;:1-10
pubmed: 33766158
J Nutr. 2003 Feb;133(2):556S-62S
pubmed: 12566502
Psychol Assess. 2000 Jun;12(2):123-31
pubmed: 10887758
J Affect Disord. 2016 Sep 01;201:95-8
pubmed: 27195513
Acta Psychiatr Scand. 2016 Feb;133(2):144-153
pubmed: 26114830
Psychosom Med. 2022 Jan 1;84(1):97-103
pubmed: 34611111
J Clin Psychiatry. 2001 Jun;62(6):486-91; quiz 492-3
pubmed: 11465534
Nutr Rev. 2015 Oct;73(10):643-60
pubmed: 26307238
J Am Diet Assoc. 2010 Mar;110(3):383-9
pubmed: 20184988
Eur J Nutr. 2014 Jun;53(4):997-1013
pubmed: 24468939
J Affect Disord. 2021 Mar 1;282:637-643
pubmed: 33445086
J Nutr. 2014 Mar;144(3):399-407
pubmed: 24453128
Acta Psychiatr Scand. 2020 Jul;142(1):58-65
pubmed: 32335894
J Acad Nutr Diet. 2012 May;112(5):693-8
pubmed: 22709773
Bipolar Disord. 2020 Aug;22(5):440-460
pubmed: 32356562
PLoS One. 2012;7(6):e36889
pubmed: 22719834
Int J Obes (Lond). 2021 Jan;45(1):225-234
pubmed: 33188301
Contemp Clin Trials. 2018 Jul;70:8-14
pubmed: 29680319
Int J Methods Psychiatr Res. 2008;17(4):198-209
pubmed: 18792087
J Am Coll Cardiol. 2020 Nov 10;76(19):2181-2193
pubmed: 33153576
Nutr Neurosci. 2022 Sep;25(9):1948-1955
pubmed: 33939946
Br J Psychiatry. 2009 Nov;195(5):408-13
pubmed: 19880930
Lancet Planet Health. 2020 Aug;4(8):e352-e370
pubmed: 32800153
Int J Bipolar Disord. 2015 Dec;3(1):30
pubmed: 26105627
Bipolar Disord. 2014 May;16(3):277-88
pubmed: 24330321
J Nutr Educ Behav. 2006 Sep-Oct;38(5):286-92
pubmed: 16966049
J Affect Disord. 2019 Feb 15;245:174-179
pubmed: 30391773
Nutr J. 2018 Sep 28;17(1):89
pubmed: 30266095
J Affect Disord. 2019 Apr 15;249:394-403
pubmed: 30822662
J Affect Disord. 2021 Mar 1;282:1076-1081
pubmed: 33601680
J Affect Disord. 2016 Apr;194:120-7
pubmed: 26820761
Acta Psychiatr Scand. 2007 Sep;116(3):189-94
pubmed: 17655560
Nutr Neurosci. 2019 Jul;22(7):474-487
pubmed: 29215971
JAMA Psychiatry. 2020 Jun 1;77(6):598-606
pubmed: 31995135
Mol Psychiatry. 2019 Jul;24(7):965-986
pubmed: 30254236
J Affect Disord. 2012 Dec 1;141(1):1-10
pubmed: 22497876
Obesity (Silver Spring). 2010 Feb;18(2):347-53
pubmed: 19590500
AIDS Behav. 2006 Nov;10(6):659-70
pubmed: 16770694
N Engl J Med. 2011 Jan 6;364(1):51-9
pubmed: 21208108
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1221-1238
pubmed: 30779092
J Affect Disord. 2011 Mar;129(1-3):332-7
pubmed: 20888648
Nutrients. 2020 Apr 24;12(4):
pubmed: 32344617
Br J Psychiatry. 2019 May;214(5):251-259
pubmed: 30784395
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790
J Eat Disord. 2019 Sep 12;7:32
pubmed: 31528342
Nutr Metab Cardiovasc Dis. 2015 Nov;25(11):988-96
pubmed: 26482566

Auteurs

Manuel Gardea-Resendez (M)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Stacey J Winham (SJ)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Francisco Romo-Nava (F)

Lindner Center of HOPE/Department of Psychiatry and Behavioral Neurosciences, University of Cincinnati College of Medicine, Mason, OH, USA.

Alfredo Cuellar-Barboza (A)

Department of Psychiatry, Universidad Autónoma de Nuevo León, Monterrey, Mexico.

Matthew M Clark (MM)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Ana Cristina Andreazza (AC)

Department of Pharmacology and Toxicology and Psychiatry, University of Toronto, Temerty Faculty of Medicine, Toronto, Canada.

Alejandra Cabello-Arreola (A)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Marin Veldic (M)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

David J Bond (DJ)

Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, MN, USA.

Balwinder Singh (B)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Miguel L Prieto (ML)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA; Department of Psychiatry, Facultad de Medicina, Universidad de los Andes, Santiago, Chile; Mental Health Service, Clínica Universidad de los Andes, Santiago, Chile; Center for Biomedical Research and Innovation, Universidad de los Andes, Santiago, Chile.

Nicolas A Nunez (NA)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Hannah Betcher (H)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Katherine M Moore (KM)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Thomas Blom (T)

Lindner Center of HOPE/Department of Psychiatry and Behavioral Neurosciences, University of Cincinnati College of Medicine, Mason, OH, USA.

Colin Colby (C)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Richard S Pendegraft (RS)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Sydney S Kelpin (SS)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Aysegul Ozerdem (A)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.

Alessandro Miola (A)

Department of Neurosciences, Psychiatry Unit, University-Hospital of Padova, Padova, Italy.

Eleanna De Filippis (E)

Department of Endocrinology, Mayo Clinic, Scottsdale, AZ, USA.

Joanna M Biernacka (JM)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Susan L McElroy (SL)

Lindner Center of HOPE/Department of Psychiatry and Behavioral Neurosciences, University of Cincinnati College of Medicine, Mason, OH, USA.

Mark A Frye (MA)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA. Electronic address: mfrye@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH